Differential Involvement of Α4β2, Α7 and Α9α10 Nicotinic Acetylcholine Receptors in B Lymphocyte Activation in Vitro

Lyudmyla Koval,Olena Lykhmus,Maxim Zhmak,Alexey Khruschov,Victor Tsetlin,Elena Magrini,Antonella Viola,Alexander Chernyavsky,Jing Qian,Sergei Grando,Sergei Komisarenko,Maryna Skok
DOI: https://doi.org/10.1016/j.biocel.2010.12.003
2011-01-01
Abstract:Mouse B lymphocytes express several nicotinic acetylcholine receptor (nAChR) subtypes, their exact functions being not clearly understood. Here we show that α7 nAChR was present in about 60%, while α4β2 and α9(α10) nAChRs in about 10% and 20% of mouse spleen B lymphocytes, respectively; Balb/c and C57Bl/6 mice possessed different relative amounts of these nAChR subtypes. α4β2 and α7, but not α9(α10) nAChRs, were up-regulated upon B lymphocyte activation in vitro. Flow cytometry and sandwich ELISA studies demonstrated that α7 and α9(α10) nAChRs are coupled to CD40, whereas α4β2 nAChR is coupled to IgM. B lymphocytes of both α7−/− and β2−/− mice responded to anti-CD40 stronger than those of the wild-type mice, whereas the cells of β2−/− mice responded to anti-IgM worse than those of the wild-type or α7−/− mice. Inhibition of α7 and α9(α10) nAChRs with methyllicaconitine resulted in considerable augmentation of CD40-mediated B lymphocyte proliferation in cells of all genotypes; stimulation of α4β2 nAChRs with epibatidine increased the IgM-mediated proliferation of the wild-type and α7−/−, but not β2−/− cells. Inhibition of α9(α10) nAChRs with α-conotoxin PeAI exerted weak stimulating effect on CD40-mediated proliferation. This nAChR subtype was up-regulated in α7−/− B-cells. α7 nAChRs were found recruited to immune synapses between human T and B lymphocytes, both of which produced acetylcholine. It is concluded that α7 nAChR fulfills inhibitory CD40-related mitogenic function, α4β2 nAChR produces a stimulatory IgM-related effect, while α9α10 nAChR is a “reserve” receptor, which partly compensates the absence of α7 nAChR in α7−/− cells. Acetylcholine is an additional mediator to modulate activation of interacting T and B lymphocytes.
What problem does this paper attempt to address?